India to United States: Extract Export Trade Route
India has recorded 99 verified shipments of Extract exported to United States, representing a combined trade value of $794.9K USD. This corridor is served by 27 active Indian exporters, with an average shipment value of $8.0K USD. The leading Indian exporter is AMOL PHARMACEUTICALS PRIVATE LIMITED, which accounts for 29% of total export value with 5 shipments worth $229.0K USD. On the buying side, M/S. US PHARMA LAB LLC is the largest importer in United States with $130.8K USD in purchases. The top 3 suppliers — AMOL PHARMACEUTICALS PRIVATE LIMITED, WELEX LABORATORIES PRIVATE LIMITED, CULTIVATOR NATURAL PRODUCTS PRIVATE LIMITED — together control 60% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Extract corridor is one of India's established pharmaceutical export routes, with 99 shipments documented worth a combined $794.9K USD. The route is dominated by AMOL PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's extract manufacturing sector.
Across 27 active suppliers, the average shipment value stands at $8.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with extract's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 12.2%, placing it at rank #20 among India's top extract export destinations globally.
On the import side, key buyers of Indian extract in United States include M/S. US PHARMA LAB LLC, M/S. GLOBAL MARKETING ASSOCIATES I, A TO Z IMPORTS LLC and 42 others. M/S. US PHARMA LAB LLC is the single largest importer with 2 shipments valued at $130.8K USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#20
- Annual growth+12.2%
- Demand growth+12.7%
- Regulatory ease88/100
Top 10 Indian Extract Exporters to United States
Showing top 10 of 27 Indian suppliers exporting Extract to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AMOL PHARMACEUTICALS PRIVATE LIMITED Avg $45.8K per shipment | 5 | $229.0K | 28.8% |
| 2 | WELEX LABORATORIES PRIVATE LIMITED Avg $16.5K per shipment | 11 | $181.9K | 22.9% |
| 3 | CULTIVATOR NATURAL PRODUCTS PRIVATE LIMITED Avg $12.8K per shipment | 5 | $64.2K | 8.1% |
| 4 | DELLICCIO By J Avg $29.5K per shipment | 2 | $58.9K | 7.4% |
| 5 | VOVANTIS LABORATORIES PRIVATE LIMITED Avg $14.5K per shipment | 4 | $58.1K | 7.3% |
| 6 | ENOVATE BIOLIFE PRIVATE LIMITED Avg $27.6K per shipment | 2 | $55.3K | 7.0% |
| 7 | SAB HERBALS & NUTRACEUTICALS Avg $26.4K per shipment | 2 | $52.9K | 6.7% |
| 8 | AMOL PHARMACEUTICALS PVT LTD Avg $33.1K per shipment | 1 | $33.1K | 4.2% |
| 9 | DELLICCIO BY J Avg $25.0K per shipment | 1 | $25.0K | 3.1% |
| 10 | ASTRON LIFESCIENCES PRIVATE LIMITED Avg $1.7K per shipment | 14 | $23.5K | 3.0% |
This table shows the top 10 of 27 Indian companies exporting extract to United States, ranked by total trade value. The listed exporters are: AMOL PHARMACEUTICALS PRIVATE LIMITED, WELEX LABORATORIES PRIVATE LIMITED, CULTIVATOR NATURAL PRODUCTS PRIVATE LIMITED, DELLICCIO By J, VOVANTIS LABORATORIES PRIVATE LIMITED, ENOVATE BIOLIFE PRIVATE LIMITED, SAB HERBALS & NUTRACEUTICALS, AMOL PHARMACEUTICALS PVT LTD, DELLICCIO BY J, ASTRON LIFESCIENCES PRIVATE LIMITED. AMOL PHARMACEUTICALS PRIVATE LIMITED is the dominant supplier with 5 shipments worth $229.0K USD, giving it a 29% market share. The top 3 suppliers together account for 60% of the total trade value on this route.
Showing top 10 of 27 total Indian exporters on the India to United States Extract export route.
Top 10 Extract Importers in United States
Showing top 10 of 45 known buyers in United States receiving Extract shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian extract in United States include M/S. US PHARMA LAB LLC, M/S. GLOBAL MARKETING ASSOCIATES I, A TO Z IMPORTS LLC, RARITAN PHARMACEUTICALS INC., MS US PHARMA LAB INC, among 45 total buyers. The largest importer is M/S. US PHARMA LAB LLC, accounting for $130.8K USD across 2 shipments — representing 16% of all extract imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S. US PHARMA LAB LLC | 2 | $130.8K | 16.5% |
| 2 | M/S. GLOBAL MARKETING ASSOCIATES I | 5 | $86.6K | 10.9% |
| 3 | A TO Z IMPORTS LLC | 3 | $83.9K | 10.6% |
| 4 | RARITAN PHARMACEUTICALS INC. | 4 | $58.1K | 7.3% |
| 5 | MS US PHARMA LAB INC | 2 | $55.6K | 7.0% |
| 6 | TO THE ORDER OF PURCHASE MANAGER | 2 | $55.3K | 7.0% |
| 7 | PHARBEST PHARMACEUTICALS, INC. | 2 | $52.9K | 6.7% |
| 8 | BANYAN TRADING CO. | 4 | $52.0K | 6.5% |
| 9 | M s US PHARMA LAB INCORPORATED | 1 | $40.3K | 5.1% |
| 10 | US PHARMA LAB LLC, | 1 | $35.3K | 4.4% |
Showing top 10 of 45 Extract importers in United States on this route.
Top 10 Extract Formulations Imported by United States
Showing top 10 of 77 product formulations shipped on the India to United States Extract route, ranked by trade value
United States imports a wide range of extract formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HERBAL MEDICAMENTS-BOSWELLIA SERRATA EXTRACT GRANULES(SHALLAKI GUGGUL)B/NO.H-1971,H-1972,MFG DT-11/2023,EXP DT-10/2026 — accounts for $114.6K USD across 1 shipments. There are 77 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HERBAL MEDICAMENTS-BOSWELLIA SERRATA EXTRACT GRANULES(SHALLAKI GUGGUL)B/NO.H-1971,H-1972,MFG DT-11/2023,EXP DT-10/2026 | 1 | $114.6K | 14.4% |
| 2 | MEDICAMENTS OF AYURVEDIC SYSTEM CONTAINING HERBS GRINDED POWDER AND EXTRACTS AYURVEDIC FORMULA (BLEND) NO. 3 | 3 | $52.9K | 6.6% |
| 3 | MEDICAMENTS OF AYURVEDIC SYSTEM CONTAINING HERBS GRINDED POWDER AND EXTRACTS AYURVEDIC FORMULA (BLEND) NO. 1 | 3 | $48.9K | 6.1% |
| 4 | HEEZON POWDER (MEDICAMENTS OF AYURVEDICSYSTEM) CONTAINING STANDARDIZED EXTRACTDERIVED FROM TRIBULUS ** | 1 | $46.8K | 5.9% |
| 5 | Herbal Medicaments Boswellia Serrata Extract Granules Shallaki Guggul | 1 | $40.3K | 5.1% |
| 6 | Herbal Medicaments Boswellia Serrata Extract Granules (Shallaki Guggul) | 1 | $35.3K | 4.4% |
| 7 | CALCIUM SENNOSIDES 20% USP (Senna Dry Extract) DETAILS AS PER INVOICE & PACKING LIST | 1 | $35.1K | 4.4% |
| 8 | HERBAL MEDICAMENTS- BOSWELLIA SERRATA EXTRACT GRANULES SHALLAKI GUGGUL BATCH NO.H-1970, MANUFACTURING DT-09/2023,EXP DT-08/2026 | 1 | $33.1K | 4.2% |
| 9 | MEDICAMENTS OF AYURVEDIC SYSTEM CONTAINING HERBS GRINDED POWDER AND EXTRACTS JNT-AV BLEND | 2 | $32.7K | 4.1% |
| 10 | IMMUNE SUPPORT SUPPLEMENT WITH HERBAL EXTRACT CHEWABLE TABLET ORANGE FLAVOUR Per Packets = 500 Tabs , Total Packets = 64 | 1 | $32.5K | 4.1% |
Showing top 10 of 77 Extract formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 21 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's extract exports to United States are driven primarily by a handful of large-scale manufacturers. AMOL PHARMACEUTICALS PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 27 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AMOL PHARMACEUTICALS PRIVATE LIMITED, WELEX LABORATORIES PRIVATE LIMITED, CULTIVATOR NATURAL PRODUCTS PRIVATE LIMITED — together account for 60% of total trade value on this route. The average shipment value of $8.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as medicaments of ayurvedic system containing herbs grinded powder and extracts ayurvedic formula (blend) no. 3 and medicaments of ayurvedic system containing herbs grinded powder and extracts ayurvedic formula (blend) no. 1, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, M/S. US PHARMA LAB LLC is the largest importer with 2 shipments worth $130.8K USD — representing 16% of all extract imports from India on this route. A total of 45 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $794.9K
- Avg. Shipment
- $8.0K
- Suppliers
- 27
- Buyers
- 45
- Transit (Sea)
- ~26 days
- Annual Growth
- +12.2%
Other Extract Routes
Unlock the Full India to United States Extract Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 99 shipments on this route.
Frequently Asked Questions — India to United States Extract Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Extract to United States?
The leading Indian exporters of Extract to United States are AMOL PHARMACEUTICALS PRIVATE LIMITED, WELEX LABORATORIES PRIVATE LIMITED, CULTIVATOR NATURAL PRODUCTS PRIVATE LIMITED. AMOL PHARMACEUTICALS PRIVATE LIMITED holds the largest market share at approximately 29% of total trade value on this route.
Q What is the total value of Extract exports from India to United States?
India exports Extract to United States worth approximately $794.9K USD across 99 recorded shipments. The average value per shipment is $8.0K USD.
Q Which ports does India use to ship Extract to United States?
The most active port of origin is DELHI AIR with 21 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to United States for Extract?
The average transit time for Extract shipments from India to United States is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Extract trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.2% with demand growth tracking at 12.7%. The route is ranked #20 among India's top Extract export destinations globally.
Q How many suppliers are active on the India to United States Extract route?
There are currently 27 active Indian suppliers exporting Extract to United States. The market is moderately concentrated with AMOL PHARMACEUTICALS PRIVATE LIMITED accounting for 29% of total shipment value.
Q Who are the main importers of Extract from India in United States?
The leading importers of Indian Extract in United States include M/S. US PHARMA LAB LLC, M/S. GLOBAL MARKETING ASSOCIATES I, A TO Z IMPORTS LLC, RARITAN PHARMACEUTICALS INC., MS US PHARMA LAB INC. M/S. US PHARMA LAB LLC is the largest buyer with 2 shipments worth $130.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Extract.
- 2.Supplier/Buyer Matching: 27 Indian exporters and 45 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 99 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
99 Verified Shipments
27 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists